# L19TNFα in Patients With Advanced Solid Tumors

> **NCT01253837** · PHASE1,PHASE2 · COMPLETED · sponsor: **Philogen S.p.A.** · enrollment: 34 (estimated)

## Conditions studied

- Solid Tumors
- Colorectal Cancer

## Interventions

- **DRUG:** L19TNFa

## Key facts

- **NCT ID:** NCT01253837
- **Lead sponsor:** Philogen S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-09
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2011-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01253837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01253837, "L19TNFα in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT01253837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*